(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMPOSTO E COMPOSIÇÃO FARMACÊUTICA

ConcedidaInvention PatentPCT · AU2016000095

Application data

Number

112017019824

Type

Invention Patent

Filing

03/18/2016

Publication

05/29/2018

PCT

AU2016000095

Progress at the INPI

  1. Filing03/18/16
  2. Publication05/29/18
  3. Examination
  4. Allowance12/06/22
  5. Grant02/23/23
  6. In force03/18/36

The patent was granted on 02/23/2023 and is in force until 03/18/2036. Until then, no one may make, use or sell the invention in Brazil without the owner's authorisation.

Protection valid until:03/18/2036

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 02/23/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

VECTUS BIOSYSTEMS LIMITED

AU

See this company's full portfolio

Inventors

K. D. (pessoa física)

AU

Technical data

Priority claims

AU

2015900979 · 03/18/2015

Abstract

A presente invenção refere-se a novos compostos e ao seu uso no tratamento profilático e/ou terapêutico da fibrose e de patologias relacionadas com a fibrose.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Concessão da patente

#16.1

Prazo de Validade: 20 (vinte) anos contados a partir de 18/03/2016, observadas as condições legais

02/23/2023

RPI 2720

Deferimento

#9.1

12/06/2022

RPI 2709

Exigência - art. 36 da LPI

#6.1

10/11/2022

RPI 2701

Exigência preliminar

#6.21

10/20/2020

RPI 2598

Não anuência — art. 229 da LPI

#7.5

09/08/2020

RPI 2592

Ciência (anuência ANVISA - art. 229-C)

#7.4

05/12/2020

RPI 2575

Notificação de entrada na fase nacional - PCT

#1.3

05/29/2018

RPI 2473

Alteração de dados cadastrais

#1.1

09/26/2017

RPI 2438

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.